Luteinizing hormone and follicle-stimulating hormone levels in extreme prematurity: Development of reference intervals

Pediatrics

Volumn 121, Issue 3, 2008, Pages

  Greaves, Ronda F ^a,b   Hunt, Rodney W ^a   Chmano, Angela S ^a   Zacharin, Margaret R ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Extremely premature infants; Foliicle sttmulating hormone; Luteinizing hormone; Reference range

Indexed keywords

FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE; BIOLOGICAL MARKER;

ARTICLE; CHEMOLUMINESCENCE; FEMALE; GENITAL MALFORMATION; GESTATIONAL AGE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCHEMILUMINOMETRIC IMMUNOASSAY; INFANT; LABORATORY AUTOMATION; MAJOR CLINICAL STUDY; MALE; PREMATURITY; PRIORITY JOURNAL; REFERENCE VALUE; BLOOD; CHEMISTRY; CHILD DEVELOPMENT; COHORT ANALYSIS; EPIDEMIOLOGY; EXTREMELY LOW BIRTH WEIGHT; FETUS BLOOD; FOLLOW UP; METABOLISM; NEWBORN; PHYSIOLOGY; PREDICTION AND FORECASTING; PREGNANCY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; CHILD DEVELOPMENT; COHORT STUDIES; FEMALE; FETAL BLOOD; FOLLICLE STIMULATING HORMONE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; LUTEINIZING HORMONE; MALE; PREDICTIVE VALUE OF TESTS; PREGNANCY; REFERENCE VALUES; RISK ASSESSMENT; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 40949145744     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2007-1327     Document Type: Article

References (13)

1. Verras P, Greaves R. Abnormal laboratory results: important issues to consider in the interpretation of paediatric biochemistry. Aust Prescriber. 2005;28(5):126-129
2. National Health and Medical Research Council. Care Around Preterm Birth. Clinical Practice Guidelines. Canberra, Australia: Australian Government Publishing Service; 1997
3. Greaves R, Kanumakala S, Read A, Zacharin M. Transient 3 beta HSD deficiency and ambiguous genitalia in premature babies. J Paediatr Child Health. 2004;40(4):233-236
4. Kaplan S, Grumbach M. The ontogenesis of human foetal hormones. II. Luteinizing hormone (LH) and follicle stimulating hormone (FSH). Acta Endocrinol. I976;81(4):808-829
5. Shinkawa O, Furuhashi N, Fukaya T, Suzuki M, Kono H, Tachibana Y. Changes of serum gonadotropins levels and sex difference in premature and mature infants during neonatal life. J Clin Endocrinol Metab. 1983;56(6):1327-1331
6. Massa G, de Zegher F, Vanderschueren-Lodeweyckx. Serum levels of immunoreactive inhibin, FSH, and LH in human infants at preterm and term birth. Biol Neonate. 1992;61(3): 150-155
7. Trotter A, Maier L, Grill H-J, Kohn T, Heckmann M, Pohlandt F. Effects of postnatal estradiol and progesterone replacement in extremely preterm infants. J Clin Endocrinol Metab. 1999; 84(12):4531-4535
8. Solberg HE. Establishment and Use of Reference Values in Tietz Textbook of Clinical Chemistry. 2nd ed. Philadelphia, PA: WB Saunders Company; 1994:454-484
9. Schmidt H, Schwarz HP. Serum concentrations of LH and FSH in the healthy newborn. Eur J Endocrinol. 2000; 143 (2) :21 3-21 5
10. Midgley PC, Russell K, Oates N, Shaw JCL, Honour JW. Activity of the adrenal fetal zone in preterm infants continues to term. Endocr Res. 1996;22(4):729-733
11. Corbier P, Dehennin L, Castanier M, Mebazaa A, Edwards D, Roffi J. Sex differences in serum luteinizing hormone and testosterone in the human neonate during the first few hours after birth. J Clin Endocrinol Metab. 1990;71 (5):1344-1348
12. Mercado M Yu VY, Fancis I, Szymonowicz W, Gold H. Thyroid function in very preterm infants. Early Hum Dev. 1988;16(2-3): 131-141
13. Sikaris K. McLachlan R, Kazlauskas R, de Kretser D, Holden C, Handelsman D. Reproductive hormone reference intervals for healthy fertile young men: evaluation of automated platform assays. J Clin Endocrinol Metab. 2005;90(11):5928-5936